S V Rao1, M A Bethel, M N Feinglos. Show Affiliations » 1. Department of Medicine, Duke University Medical Center, Durham, NC, 27710, USA.
Abstract
Entities: Disease
Mesh： See more » Acarbose/administration & dosageAdministration, OralBlood Glucose/metabolismCardiovascular Diseases/epidemiologyCardiovascular Diseases/etiologyCardiovascular Diseases/prevention & controlDiabetes Mellitus, Type 2/bloodDiabetes Mellitus, Type 2/complicationsDiabetes Mellitus, Type 2/drug therapyGlycated Hemoglobin A/metabolismHumansHypoglycemic Agents/administration & dosageIncidenceInsulin/bloodMetformin/administration & dosageSulfonylurea Compounds/administration & dosageSurvival Rate
Substances： See more » Blood GlucoseGlycated Hemoglobin AHypoglycemic AgentsInsulinSulfonylurea CompoundsglimepirideMetforminAcarbose
Year: 1999 PMID： 10539794 DOI： 10.1016/s0002-8703(99)70032-3
Source DB: PubMed Journal: Am Heart J ISSN： 0002-8703 Impact factor: 4.749